"Designing Growth Strategies is in our DNA"

High Intensity Focused Ultrasound Market Size, Share & Industry Analysis, By Product Type (Instruments and Consumables & Accessories), By Application (Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics & Cosmetology, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, Physiotherapy & Rehabilitation Centers, Diagnostic Imaging Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: June 15, 2026 | Format: PDF | Report ID: FBI100723

 

High Intensity Focused Ultrasound Market Overview

Play Audio Listen to Audio Version

The global high intensity focused ultrasound market size was valued at USD 1.25 billion in 2025. The market is projected to grow from USD 1.34 billion in 2026 to USD 2.43 billion by 2034, exhibiting a CAGR of 7.7% during the forecast period. North America dominated the high intensity focused ultrasound market with a market share of 32.8% in 2025.

High intensity focused ultrasound (HIFU) is a non-invasive therapeutic ultrasound technology that focuses acoustic energy on a defined target to ablate tissue or stimulate collagen without open surgery. The market is witnessing significant growth due to the rising preference for incision-free treatments in neurology, oncology, urology, vascular care, and medical aesthetics, expanding regulatory approvals, and broader installation of robotic/MRI-guided platforms.

Insightec, EDAP TMS, and Sonablate Corp held the highest market share in 2025 due to their broad portfolios of products differentiated via clinical indications.

High Intensity Focused Ultrasound Market

Download Free sample to learn more about this report.

Integration of AI, Robotics, Real-Time Imaging, and Platform Compatibility to Emerge as a Key Trend

Currently, there has been an increasing integration of HIFU with MRI guidance, AI planning, robotic targeting, real-time thermometry, and broader scanner compatibility. These innovations are improving treatment precision, workflow efficiency, and physician confidence, which is helping manufacturers position HIFU as a platform technology rather than a single-indication device. In response, key players are unveiling novel products to enhance the scenario.

  • For instance, in November 2024, Profound Medical unveiled its third TULSA-AI module, the UA Alignment Assistant, at RSNA 2024, alongside presentations highlighting the TULSA procedure’s flexibility, real-world efficacy, and CAPTAIN study data.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Incidence of Prostate Cancer, Neurological Disorders, and Urological Conditions to Fuel Market Expansion

Over the past few years, there has been a significant surge in conditions such as prostate cancer cases, neurological disorders, and urological conditions, which has increased the demand for treatments that reduce hospital stay, surgical trauma, bleeding, scarring, and recovery time. In such a scenario, HIFU devices address this need by enabling targeted tissue ablation or lifting without incisions, making it attractive and driving the global high intensity focused ultrasound market growth in the forthcoming years.

  • For instance, according to the American Cancer Society, an estimated 313,780 new cases of prostate cancer were expected in the U.S. in 2025.

MARKET RESTRAINTS

High System Cost, Reimbursement Dependency, and Regulatory Complexity to Restrict Market Growth

High intensity focused ultrasound systems require advanced imaging, robotics, specialized probes/consumables, trained physicians, and lengthy regulatory pathways, which leads to an increase in overall costs and slows down adoption in cost-sensitive hospitals and emerging markets. Moreover, the limited reimbursement for such procedures also remains a critical barrier, especially for newer indications, ultimately leading to the limited purchase of HIFU systems. These factors are anticipated to hinder the market growth over the forecast period.

MARKET OPPORTUNITIES

Expansion into New Indications and Outpatient Care Models to Offer Lucrative Opportunities

Currently, the largest opportunity for key players lies in expanding HIFU beyond prostate cancer and aesthetics into neurology, women’s health, vascular disease, benign prostatic hyperplasia, endometriosis, and drug-delivery applications. These expanded indications are further expected to increase the overall demand and sales of HIFU systems and consumables & accessories of key players, contributing to market expansion in the near future.

  • For instance, in November 2022, EDAP TMS received approval to begin a Phase 3 trial evaluating Focal One HIFU for rectal deep infiltrating endometriosis, while Theraclion is developing SONOVEIN for varicose veins.

MARKET CHALLENGES

Shortage of Skilled Professionals to Challenge Market Expansion

A successful treatment with high intensity focused ultrasound (HIFU) systems requires expertise in ultrasound physics, image-guided targeting, patient selection, treatment planning, and post-procedure monitoring, as these therapies are performed in specialized areas such as urology, oncology, neurology, vascular care, and aesthetics. In such cases, the limited availability of skilled operators is expected to restrict adoption, especially in emerging markets and smaller specialties, thereby challenging the market growth.

Segmentation Analysis

By Product Type

Recurring Demand for Consumables & Accessories to Fuel the Segment Growth

Based on product type, the market is segmented into instruments and consumables & accessories.

To know how our report can help streamline your business, Speak to Analyst

The consumables & accessories segment accounted for the largest market share in 2025. The growth is attributed to the recurring demand for cartridges, handpieces, probes, patient-contact accessories, treatment tips, coupling media, and procedure-specific disposables generated by HIFU platforms.

  • For instance, according to Classys annual report 2025, consumables accounted for 46.0% of total company revenue that year, supported by more than 5.5 million HIFU procedures performed worldwide using its devices.

Additionally, the instruments segment is projected to grow at a CAGR of 6.4% during the forecast period.

By Application

Increasing Demand for HIFU-based Aesthetic Procedures to Boost the Aesthetics & Cosmetology Segment Growth

By application, the market is classified into prostate cancer, uterine fibroids, neurological disorders, aesthetics & cosmetology, and others.

The aesthetics & cosmetology segment accounted for the largest high intensity focused ultrasound market share in 2025. The growth is attributed to HIFU-based skin-tightening, lifting, wrinkle-reduction, and contouring procedures, which are widely delivered in dermatology and aesthetic clinics. Moreover, the segment is projected to hold a share of 44.5% in 2026.

Additionally, the prostate cancer segment is expected to grow at a CAGR of 6.5% during the forecast period.

By End-user

Increasing Number of HIFU Procedures in Specialty Clinics to Propel the Segment Growth

On the basis of end-user, the market is segmented into hospitals & ASCs, specialty clinics, physiotherapy & rehabilitation centers, diagnostic imaging centers, and others.

In 2025, the specialty clinics segment dominated the market. These settings perform the largest number of HIFU procedures and benefit from shorter procedures, outpatient workflows, premium cash-pay aesthetic demand, and specialist-led adoption. As a result, there is an increase in partnerships between clinics and product suppliers, which is expected to support the segment’s growth. Furthermore, the segment is set to hold a share of 43.5% in 2026.

  • For instance, in January 2021, SonaCare Medical announced that Mayo Clinic had purchased its Sonablate system. This marked a significant step toward expanding the use of its focused ultrasound technology for prostate treatment within one of the leading U.S. healthcare institutions.

In addition, the hospitals & ASCs segment is projected to grow at a CAGR of 7.1% during the forecast period.

High Intensity Focused Ultrasound Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America High Intensity Focused Ultrasound Market Size, 2025 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest share of revenues in 2024, valued at USD 0.38 billion, and reached a value of USD 0.41 billion in 2025. The growth is attributed to the strong adoption of advanced non-invasive treatment options, the presence of key companies, favorable clinical research activity, and faster regulatory approvals for HIFU-based treatments in the region.

  • For instance, in July 2025, Insightec received the U.S. FDA approval for staged bilateral focused ultrasound treatment for Parkinson’s disease using Exablate Neuro, strengthening the adoption of incisionless neurosurgical procedures.

U.S. High Intensity Focused Ultrasound Market

In 2026, the U.S. market is anticipated to reach USD 0.39 billion, accounting for approximately 29.4% of the global market.

Europe

The Europe market is projected to record a growth rate of 6.8% during the forecast period, the third-highest globally. The market is anticipated to reach a value of USD 0.34 billion by 2026. The region’s growth is attributed to established healthcare infrastructure, which is supporting the increasing acceptance of non-invasive therapies, such as HIFU-based treatments for prostate cancer, dermatology, neurological disorders, and others.

U.K. High Intensity Focused Ultrasound Market

The U.K. market is projected to reach USD 0.06 billion by 2026, representing approximately 4.4% of global revenues.

Germany High Intensity Focused Ultrasound Market

The Germany market is expected to reach USD 0.08 billion by 2026, accounting for approximately 6.0% of the global revenue.

Asia Pacific

By 2026, the Asia Pacific market is projected to reach approximately USD 0.38 billion, making it the second-largest market worldwide. The growth is attributed to the region’s large patient pool of prostate cancer, urological conditions, neurological disorders, dermatological conditions, and others in China, Japan, India, and South Korea. This is influencing key players to expand the reach of their products in the region.

Japan High Intensity Focused Ultrasound Market

The Japan market is projected to generate approximately USD 0.09 billion in revenue by 2026, representing nearly 7.0% of the global market.

China High Intensity Focused Ultrasound Market

The China market is anticipated to reach around USD 0.19 billion by 2026, accounting for nearly 13.8% of global revenues.

India High Intensity Focused Ultrasound Market

The India market is expected to reach approximately USD 0.03 billion by 2026, accounting for around 2.6% of the global market revenue.

Latin America and Middle East & Africa

Both Latin America and the Middle East & Africa are anticipated to witness moderate growth, with the Latin America market estimated to reach approximately USD 0.12 billion by 2026. The market growth in these regions is supported by the increasing awareness of HIFU-based treatments and the expansion of healthcare infrastructure.

GCC High Intensity Focused Ultrasound Market

By 2026, the GCC market is estimated to reach approximately USD 0.03 billion, representing around 2.1% of the global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Robust Distribution Networks and Broad Product Portfolios to Strengthen the Market Position of Leading Companies

In 2025, Insightec, EDAP TMS, and Sonablate Corp held the largest high intensity focused ultrasound market share. This share is attributed to their focus on portfolio expansion through regulatory approvals, new product innovations, and portfolio acquisitions.

Moreover, other key players are focused on increasing their market reach through partnerships and acquisitions. Moreover, they are focusing on geographical expansion and strengthening distribution networks to enhance their market share in the forthcoming years.

LIST OF KEY HIGH INTENSITY FOCUSED ULTRASOUND COMPANIES PROFILED

  • Insightec (Israel)
  • EDAP TMS (France)
  • Sonablate Corp (U.S.)
  • Profound Medical (Canada)
  • Chongqing Haifu Technology Co., Ltd (China)
  • Theraclion (France)
  • ALPINION MEDICAL SYSTEMS Co., Ltd (South Korea)
  • CLASSYS Inc. (South Korea)
  • HIRONIC Co., Ltd (South Korea)
  • EUNSUNG GLOBAL (South Korea)

KEY INDUSTRY DEVELOPMENTS

  • September 2025: Theraclion received EU MDR certification for SONOVEIN, strengthening its commercial potential in the varicose vein treatment market.
  • September 2025: Theraclion announced successful U.S. FDA pivotal study results for SONOVEIN, reporting 96.8% occlusion at 12 months.
  • April 2025: Sofwave Medical launched its new liftHD body contouring applicator at the 44th Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS 2025) in Orlando. The new solution is a next‑generation, non‑invasive device designed to treat cellulite and skin laxity beyond the face.
  • December 2024: Profound Medical entered a definitive co-marketing and co-sales agreement with Siemens Healthineers. The move aimed at commercializing a complete MRI-guided prostate therapy solution combining TULSA-PRO with Siemens MAGNETOM Free.Max MR scanner.
  • November 2024: Insightec secured FDA approval and the CE Mark for Exablate Prime on selected Philips MR systems.
  • September 2024: Merz Aesthetics announced the launch of Ultherapy PRIME, an FDA-cleared next-generation ultrasound skin-lifting platform.
  • November 2023: Sonablate Corp., in partnership with CanAm Scientific, announced an agreement with Clemenceau Medical Center (CMC) Hospital in Dubai, making CMC the first GCC‑based facility to offer Sonablate HIFU as a non‑invasive treatment option for prostate diseases.

REPORT COVERAGE

The report provides a comprehensive analysis of each market segment, outlining the major growth drivers, emerging trends, opportunities, restraints, and challenges influencing the industry. It further examines technological advancements, key industry developments, market share analysis, and detailed profiles of prominent market players.  Additionally, the report offers insights into the competitive landscape, regulatory scenario, and strategic initiatives undertaken by leading companies. It also highlights future growth prospects to support informed decision-making.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 7.7% from 2026-2034
Unit Value (USD Billion)
Segmentation By Product Type, Application, End-user, and Region
By Product Type 
  • Instruments
  • Consumables & Accessories
By Application
  • Prostate Cancer
  • Uterine Fibroids
  • Neurological Disorders
  • Aesthetics & Cosmetology
  • Others
By End-user
  • Hospitals & ASCs
  • Specialty Clinics
  • Physiotherapy & Rehabilitation Centers
  • Diagnostic Imaging Centers
  • Others
By Region
  • North America (By Product Type, Application, End-user, and Country)
    • U.S. (By Product Type)
    • Canada ( By Product Type)
  • Europe (By Product Type, Application, End-user, and Country/Sub-region)
    • Germany (By Product Type)
    • U.K. (By Product Type)
    • France (By Product Type)
    • Spain (By Product Type)
    • Italy (By Product Type)
    • Scandinavia (By Product Type)
    • Rest of Europe (By Product Type)
  • Asia Pacific (By Product Type, Application, End-user, and Country/Sub-region)
    • China (By Product Type)
    • Japan (By Product Type)
    • India (By Product Type)
    • Australia (By Product Type)
    • Southeast Asia (By Product Type)
    • Rest of Asia Pacific (By Product Type)
  • Latin America (By  Product Type, Application, End-user, and Country/Sub-region)
    • Brazil (By Product Type)
    • Mexico (By Product Type)
    • Rest of Latin America (By Product Type)
  • Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-region)
    • GCC (By Product Type)
    • South Africa (By Product Type)
    • Rest of the Middle East & Africa (By Product Type)


Frequently Asked Questions

Fortune Business Insights says that the global market value stood at USD 1.25 billion in 2025 and is projected to reach USD 2.43 billion by 2034.

In 2025, the North America market value stood at USD 0.41 billion.

The market is expected to exhibit a CAGR of 7.7% during the forecast period of 2026-2034.

The consumables & accessories segment led the market by product type in 2025.

A key factor driving the market is the rising incidence of prostate cancer, neurological disorders, and urological conditions.

Insightec, EDAP TMS, and Sonablate Corp are the prominent players in the market.

North America dominated the market in 2025.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 180
Download Free Sample

    man icon
    Mail icon
Jump to Content

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann